• English
  • 简体中文
Login Register
Current Location: Home > CFDA Approvals(Import) Feedback Help Print
Registration No. H20140463
Original Registration No. H20140463
Registration No. Remarks 此件为更正件,原批准日期为2014年06月16日,更正日期为2014年09月16日,原批件、注册证废止。
Drug Name(Chinese) 扎那米韦吸入粉雾剂
Drug Name(English) Zanamivir Powder for Inhalation
Proprietary Name(Chinese) 依乐韦
Proprietary Name(English) 暂无权限
Drug Sandard Code(Chines) 86978470000663
Manufacturers(English) GlaxoSmithKline Australia Pty Ltd
Production Address(English) 1061 Mountain Highway Boronia VIC 3155 Australia
State(Chinese) 澳大利亚
State(English) Australia
Dosage Form 吸入粉雾剂
Strength 5mg(以C12H20N4O7计)
Packaging 4泡/板,5板/盒
Date Issued 2019-07-22
Valid Until 2024-07-21
Category 化学药品